Cargando…
Unraveling Autonomic Dysfunction in GBA‐Related Parkinson's Disease
BACKGROUND: Patients with Parkinson's disease (PD) and GBA gene mutations (GBA‐PD) develop nonmotor complications more frequently than noncarriers. However, an objective characterization of both cardiovascular and sudomotor autonomic dysfunction using extensive clinical and instrumental measure...
Autores principales: | Devigili, Grazia, Straccia, Giulia, Cereda, Emanuele, Garavaglia, Barbara, Fedeli, Alessandro, Elia, Antonio Emanuele, Piacentini, Sylvie Hélène Marie Jeanne, Prioni, Sara, Amami, Paolo, Invernizzi, Federica, Andreasi, Nico Golfrè, Romito, Luigi Michele, Eleopra, Roberto, Cilia, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654845/ https://www.ncbi.nlm.nih.gov/pubmed/38026514 http://dx.doi.org/10.1002/mdc3.13892 |
Ejemplares similares
-
Magnetic Resonance–Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early‐Stage Tremor‐Dominant Parkinson's Disease: A Pilot Study
por: Golfrè Andreasi, Nico, et al.
Publicado: (2022) -
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
por: Colucci, Fabiana, et al.
Publicado: (2023) -
Globus Pallidus Internus Deep Brain Stimulation Using Frame-Based vs. Frameless Stereotaxy in Dystonia: A Single-Center Experience
por: Eleopra, Roberto, et al.
Publicado: (2021) -
Precision Medicine in Parkinson’s Disease: From Genetic Risk Signals to Personalized Therapy
por: Straccia, Giulia, et al.
Publicado: (2022) -
Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy
por: Fonderico, Mattia, et al.
Publicado: (2017)